Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Clinical trial NCT01730118 · COMPLETED

Trial details

NCT number: NCT01730118
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms Breast Cancer Adenocarcinomas Metastatic Solid Tumors Characterized by HER2/Neu Expression

Start date: 2013-03-04
Primary completion: 2019-12-03
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.